300 related articles for article (PubMed ID: 34143810)
1. Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
Inoue K; Kashima S
PLoS One; 2021; 16(6):e0253169. PubMed ID: 34143810
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
[TBL] [Abstract][Full Text] [Related]
3. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
4. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
5. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
6. Role of latent tuberculosis infections in reduced COVID-19 mortality: Evidence from an instrumental variable method analysis.
Takahashi H
Med Hypotheses; 2020 Nov; 144():110214. PubMed ID: 33254521
[TBL] [Abstract][Full Text] [Related]
7. Worldwide inverse correlation between Bacille Calmette-Guérin (BCG) immunization and COVID-19 mortality.
Li WX
Infection; 2021 Jun; 49(3):463-473. PubMed ID: 33495884
[TBL] [Abstract][Full Text] [Related]
8. [A summary of characteristics of the first wave of new type coronavirus epidemic and potential association with tuberculosis vaccination].
Emődy-Kiss B; Pataki Á; Deli G; Papp S; Mátyus M; Fent J
Orv Hetil; 2021 Jan; 162(4):123-134. PubMed ID: 33486464
[TBL] [Abstract][Full Text] [Related]
9. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
10. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
11. BCG vaccination and the risk of COVID 19: A possible correlation.
Ahmed SM; Nasr MA; Elshenawy SE; Hussein AE; El-Betar AH; Mohamed RH; El-Badri N
Virology; 2022 Jan; 565():73-81. PubMed ID: 34742127
[TBL] [Abstract][Full Text] [Related]
12. Influence of malaria endemicity and tuberculosis prevalence on COVID-19 mortality.
Raham TF
Public Health; 2021 May; 194():33-35. PubMed ID: 33852995
[TBL] [Abstract][Full Text] [Related]
13. Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?
Gong W; Wu X
Indian J Tuberc; 2021 Jul; 68(3):401-404. PubMed ID: 34099209
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/
Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS
Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806
[TBL] [Abstract][Full Text] [Related]
15. Trained innate immunity and resistance to Mycobacterium tuberculosis infection.
Koeken VACM; Verrall AJ; Netea MG; Hill PC; van Crevel R
Clin Microbiol Infect; 2019 Dec; 25(12):1468-1472. PubMed ID: 30807849
[TBL] [Abstract][Full Text] [Related]
16. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
Kumari P; Gupta UD; Bhagyawant SS
Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
[TBL] [Abstract][Full Text] [Related]
17. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
[TBL] [Abstract][Full Text] [Related]
18. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
19. Interferon: The invisible link in the physiopathology of COVID-19 and BCGitis?
Di Bella S; Cabas P; Antonello RM; Rizzo M
Scand J Immunol; 2020 Dec; 92(6):e12939. PubMed ID: 32697854
[No Abstract] [Full Text] [Related]
20. Is the BCG vaccine a useful tool against COVID-19?
Zhelezova G; Mateeva V; Mateev G
Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
